The Efficacy of Budesonide as Intrapolyp Injection Agent in the Management of Type 2 CRSwNP. Elzayat S, Lasheen H, Gehad I, El-Deeb ME, et al. Laryngoscope 2024;134:2085-2092.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elzayat S, Lasheen H, Gehad I, El-Deeb ME, et al. The Efficacy of Budesonide as Intrapolyp Injection Agent in the Management of Type 2 CRSwNP. Laryngoscope 2024;134:2085-2092.
PMID: 37916779